跳至主要内容
临床试验/IRCT20211020052819N1
IRCT20211020052819N1招募中3 期

Evaluation of the effect of a natural product called Capsule 4 of edible fungi based on Ganoderma, Lentinula edodes, Trametes versicolor, Grifola frondosa on clinical and laboratory symptoms, respiratory and prognosis of patients with coronavirus and monkeypox referred to the Infectious Diseases Clinic of Imam Reza Hospital in 2022

Artesh University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Admission for COVID-19 patients, ranging in age from 18 to 70 years,
  • No history for diabetes, hypertension, smoking, hypertension
  • Positive PCR test for COVID-19

排除标准

  • Patients with very large lung involvement and severe general condition and should be admitted to the intensive care unit.
  • Reluctance to continue the plan
  • Side effects that can cause the patient to stop the plan or leave the study after taking the supplement
  • Creating any unwanted digestive problems including heartburn, nausea, nausea, vomiting, diarrhea, etc.
  • Any allergies, whether skin, respiratory or other
  • Creating any side effects that did not exist before taking the supplement

研究者

发起方
Artesh University of Medical Sciences

相似试验